1. Home
  2. STRO vs SELF Comparison

STRO vs SELF Comparison

Compare STRO & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • SELF
  • Stock Information
  • Founded
  • STRO 2003
  • SELF 1983
  • Country
  • STRO United States
  • SELF United States
  • Employees
  • STRO N/A
  • SELF N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • SELF Real Estate Investment Trusts
  • Sector
  • STRO Health Care
  • SELF Real Estate
  • Exchange
  • STRO Nasdaq
  • SELF Nasdaq
  • Market Cap
  • STRO 69.1M
  • SELF 58.8M
  • IPO Year
  • STRO 2018
  • SELF N/A
  • Fundamental
  • Price
  • STRO $0.86
  • SELF $5.09
  • Analyst Decision
  • STRO Hold
  • SELF
  • Analyst Count
  • STRO 8
  • SELF 0
  • Target Price
  • STRO $3.83
  • SELF N/A
  • AVG Volume (30 Days)
  • STRO 428.5K
  • SELF 33.7K
  • Earning Date
  • STRO 08-07-2025
  • SELF 08-08-2025
  • Dividend Yield
  • STRO N/A
  • SELF 5.69%
  • EPS Growth
  • STRO N/A
  • SELF 9.99
  • EPS
  • STRO N/A
  • SELF 0.22
  • Revenue
  • STRO $104,473,000.00
  • SELF $12,707,884.00
  • Revenue This Year
  • STRO N/A
  • SELF N/A
  • Revenue Next Year
  • STRO N/A
  • SELF N/A
  • P/E Ratio
  • STRO N/A
  • SELF $23.23
  • Revenue Growth
  • STRO N/A
  • SELF 4.08
  • 52 Week Low
  • STRO $0.52
  • SELF $4.78
  • 52 Week High
  • STRO $5.17
  • SELF $5.89
  • Technical
  • Relative Strength Index (RSI)
  • STRO 55.54
  • SELF 42.08
  • Support Level
  • STRO $0.76
  • SELF $4.99
  • Resistance Level
  • STRO $0.83
  • SELF $5.16
  • Average True Range (ATR)
  • STRO 0.07
  • SELF 0.13
  • MACD
  • STRO 0.01
  • SELF -0.01
  • Stochastic Oscillator
  • STRO 52.25
  • SELF 32.50

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About SELF Global Self Storage Inc.

Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.

Share on Social Networks: